Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DROSPIRENONE
- A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
- A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants
- Estetrol/Drospirenone to Reduce the Average Size of Endometriomas
- A Study of Milvexian in Healthy Adult Females
- Drospirenone-only Pill as Emergency Contraception
- A Phase 3 Study to Evaluate the Contraceptive Efficacy, Safety, and Tolerability of LPRI-CF113
- EVALUATION OF THE COMBINATION OF ANTIOXIDANTS METIONAC FOR THE MODULATION OF METABOLIC AND ENDOCRINE PARAMETERS IN PATIENTS WITH PCOS: A PROSPECTIVE RANDOMIZED STUDY
- Effects of Drospirenone Versus Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
- Aspirin for the Management of Endometriosis-associated Pelvic Pain
- Progestin-Only Pill Use and Breastfeeding Study
- The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
- Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female Adolescents
- Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With Endometriosis
- Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440
- Continuous Versus Cyclical OCP Use in PCOS
- Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) Study
- Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam
- A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females
- Treatment Choice in Primary Dysmenorrhea
- A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Prob
- E4/DRSP Ovarian Function Inhibition Study
- Safety, Tolerability and Pharmacokinetics of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers
- LCS16 vs. COC User Satisfaction and Tolerability Study
- "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
- A Survey on Efficacy and Safety in Patients With Endometriosis
- To Evaluate the Effects of Odalasvir and AL-335 With Simeprevir on the Single-Dose Pharmacokinetics of Ethinylestradiol and Drospirenone in Healthy Female Participants
- E4/DRSP Single and Multiple Dose PK and Early QT Study
- Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction
- Effect of Food on the Bioavailability of 15 mg Estetrol/3 mg Drospirenone Tablets in Healthy Female Volunteers
- E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study
- E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study
- Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure
- YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China
- To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea
- Oral Contraceptive Therapy and Sexuality
- Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?
- Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome
- Contraceptives Containing Drospirenone and Blood Pressure
- Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles
- Continuous Versus Cyclic Oral Contraceptives for Endometriosis
- Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome
- Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants
- Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception
- Comparative Study of BAY86-5300 With a Flexible Extended Regimen for Dysmenorrhea
- Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis
- Comparison of Body Weight Change During Contraception With Belara and Yasmin
- Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome
- Assessment of Autonomic Tone in Normotensive Women Using Combined Hormonal Oral Contraceptive Containing Drospirenone
- Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome
- Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.
- Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance
- Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone
- Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome
- Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism
- Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of
- Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function
- LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
- Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: YAZ and YAZ + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) a
- Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: Yasmin and Yasmin + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafo
- Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
- A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.
- Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions
- Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.
- Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function
- Comparative Trial in Hormone Withdrawal Associated Symptoms
- Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles
- Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being
- PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives
- Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects
- YAZ Premenstrual Dysphoric Disorder (PMDD) in China
- YAZ, Oral Contraceptive Registration in China
- GA YAZ ACNE in China Phase III
- Effects of Estradiol on Menopausal Breast
- Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females
- A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS
- Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne
- Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne
- Cycle Control and Safety of E2-DRSP
- Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women
- Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.
- Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study
- The Oral Contraceptive Pill for Premenstrual Worsening of Depression
- A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles
- Oral Contraceptive and Cardiovascular Risk in PCOS
- SH T00186 in the Treatment of Primary Dysmenorrhea
- Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ
- Endometrial Safety Study
- SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study
- Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)
- Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)
- Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea
- Low-dose Hormone Therapy for Relief of Vasomotor Symptoms
- Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension
- Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)
- Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life.
- Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.
- European Active Surveillance Study (EURAS)
- Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles
- Efficacy and Safety Oral Contraceptive Study
- A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception
- Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women
Clinical trials list
click for details